Press release
Key Influencer in the Angina Pectoris Drugs Market Outlook 2025: Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pectoris Drug Market Outlook Driver
Angina Pectoris Drugs Market Outlook
The surge in cardiovascular diseases is anticipated to kick-start the expansion of the angina pectoris drug market. The scope of cardiovascular diseases includes diverse disorders affecting the heart and blood vessels, such as stroke, coronary artery disease, hypertension, and heart failure. The rising prevalence of cardiovascular diseases (CVD) is linked to numerous elements, comprising an aging demographic, poor lifestyles, and the obesity crisis. Drugs for angina pectoris like nitrates, beta-blockers, and calcium channel blockers successfully alleviate the chest pain and discomfort resulting from inadequate heart blood supply, thereby improving patients' life quality overall. For example, data released by the British Heart Foundation, a cardiovascular research charity based in the UK, revealed in September 2024 that almost 7.6 million individuals suffer from heart and circulatory diseases in the UK, distributed between around 4 million males and 3.6 million females. These ailments account for nearly 27% of the total deaths in the UK, equivalent to over 170,000 deaths annually or approximately 480 deaths daily, corresponding to one death every three minutes. Thus, the escalating incidence of cardiovascular diseases is catalyzing the angina pectoris drug market's growth.
Get Your Angina Pectoris Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report
How will the growth rate of the angina pectoris drugs market shape industry trends by 2034?
The market size for drugs treating angina pectoris has seen remarkable growth lately. It is predicted to expand from $12.32 billion in 2024 to $12.94 billion in 2025, showing a compound annual growth rate (CAGR) of 5.1%. The growth observed in the past can be traced back to factors like the widespread occurrence of cardiovascular diseases, an aging population, lifestyle influences, a rise in hypertension, and the prevalence of diabetes.
In the coming years, the market for angina pectoris drugs is projected to witness robust growth, expanding to an estimated value of "$16.55 billion by 2029 with a compound annual growth rate (CAGR) of 6.3%. The surge in growth during the forecast period can be ascribed to factors such as the escalating worldwide obesity rates, innovations in precision medicine, emphasis on preemptive cardiology, initiatives to educate patients, and research into new therapeutic destinations. The forecast period is likely to see trends such as the use of telemedicine for distant monitoring, studies on real-world evidence and outcomes, patient-focused medication education, strategic partnerships to gain market access, regulatory progressions, and quick approvals.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp
What trends are poised to drive the future success of the angina pectoris drugs market?
One significant emerging pattern seen in the angina pectoris medication market is product innovation. To maintain their market standing, leading companies operating in this market are increasingly embracing advanced techniques. For example, Hikma Pharmaceuticals PLC, a pharmaceutical company based in the UK, introduced a prefilled syringe with Labetalol Hydrochloride Injection, USP, in March 2023. The product received approval from the United States' Food and Drug Administration. In hospital settings, the 10mg/2mL PFS is utilized for managing extreme hypertension and reducing blood pressure.
Which primary segments of the angina pectoris drugs market are driving growth and industry transformations?
The angina pectoris drugs market covered in this report is segmented -
1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs
2) By Indication: Stable Angina, Unstable Angina, Prinzmetal's Angina
3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates
2) By Antiplatelet Agents: Aspirin, Clopidogrel
3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers
4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers
5) By Anti-Ischemic Agents: Ranolazine, Ivabradine
6) By Statins: Atorvastatin, Rosuvastatin
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10797
Which geographical regions are pioneering growth in the angina pectoris drugs market?
North America was the largest region in the angina pectoris drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the angina pectoris drugs market landscape?
Major companies operating in the angina pectoris drugs market include Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AERIE PHARMACEUTICALS INC., AbbVie Inc., Amgen Inc., Gilead Sciences Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Ipsen S.A., Lupin Pharmaceuticals Inc., Merck KGaA, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Servier Laboratories, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp
What Is Covered In The Angina Pectoris Drugs Global Market Report?
• Market Size Forecast: Examine the angina pectoris drugs market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the angina pectoris drugs market for a structured understanding.
• Key Players Overview: Analyze major players in the angina pectoris drugs market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the angina pectoris drugs market.
• Segment Contributions: Evaluate how different segments drive overall growth in the angina pectoris drugs market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the angina pectoris drugs market.
• Industry Challenges: Identify potential risks and obstacles affecting the angina pectoris drugs market.
• Competitive Landscape: Review strategic developments in the angina pectoris drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Angina Pectoris Drugs Market Outlook 2025: Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pectoris Drug Market Outlook Driver here
News-ID: 3892352 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
